This small-cap pharmaceutical stock soared 20 per cent! Time to buy? This small-cap pharmaceutical stock soared 20 per cent! Time to buy? The 20-DMA level lies at Rs 35 and a move above this level can attract strong buying interest. It has the potential to test the level of Rs 43, and thereafter, Rs 45 in the medium term. With rising volumes, the possibility is even more. Rohit Kale / Friday, July 1, 2022 / Article rating: 3.8 This small-cap pharmaceutical company is actively engaged in the manufacturing of veterinary APIs. It manufactures bulk drugs for top established companies.